Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Manabu Natsumeda, Kensuke Tateishi et al.|Neuro-Oncology|2022Cited by 19
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated MedulloblastomaManabu Natsumeda, Akiyoshi Kakita, Hiroaki Miyahara et al.|Journal of Neuropathology & Experimental Neurology|2020Cited by 7
Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of <i>H3F3A</i> K27M Mutation in Circulating Tumor DNA of Cerebrospinal FluidSatoshi Shibuma, Makoto Oishi, Jotaro On et al.|Pediatric Blood & Cancer|2025Cited by 4
The dual role of Schlafen11 in brain tumors: Jekyll and HydeManabu Natsumeda, Makoto Oishi, Masayasu Okada et al.|Expert Review of Anticancer Therapy|2026Cited by 0
EXTH-46. SCHLAFEN11 IS A POWERFUL BIOMARKER OF CHEMOSENSITIVITY IN MEDULLOBLASTOMASManabu Natsumeda, Charles G. Eberhart, Satoshi Nakata et al.|Neuro-Oncology|2023Cited by 0